Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation.
暂无分享,去创建一个
[1] C. Pirola,et al. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. , 2005, Blood.
[2] J. Biggs,et al. Phorbol Ester Treatment of K562 Cells Regulates the Transcriptional Activity of AML1c through Phosphorylation* , 2004, Journal of Biological Chemistry.
[3] J. Downing,et al. Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors. , 2004, Blood.
[4] N. Ahn,et al. Extracellular Signal-Regulated Kinase Induces the Megakaryocyte GPIIb/CD41 Gene through MafB/Kreisler , 2004, Molecular and Cellular Biology.
[5] J. Downing,et al. Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression. , 2004, Blood.
[6] T. Kyo,et al. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. , 2004, Blood.
[7] S. Ogawa,et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis , 2004, Nature Medicine.
[8] T. Noda,et al. The Corepressor mSin3A Regulates Phosphorylation-Induced Activation, Intranuclear Location, and Stability of AML1 , 2004, Molecular and Cellular Biology.
[9] M. Kurokawa,et al. Role of AML1/Runx1 in the pathogenesis of hematological malignancies , 2003, Cancer science.
[10] Kamaleldin E Elagib,et al. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. , 2003, Blood.
[11] A. Nordheim,et al. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. , 2003, Blood.
[12] F. Porteu,et al. IEX‐1: a new ERK substrate involved in both ERK survival activity and ERK activation , 2002, The EMBO journal.
[13] N. Fox,et al. Thrombopoietin expands hematopoietic stem cells after transplantation. , 2002, The Journal of clinical investigation.
[14] I. Matsumura,et al. Molecular Control of Megakaryopoiesis and Thrombopoiesis , 2002, International journal of hematology.
[15] K. Kaushansky,et al. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production , 2002, Oncogene.
[16] R. Kumar,et al. Divergent Regulation of the Growth-promoting GeneIEX-1 by the p53 Tumor Suppressor and Sp1* , 2002, The Journal of Biological Chemistry.
[17] Hermona Soreq,et al. Runx1/AML1 in leukemia: disrupted association with diverse protein partners. , 2002, Leukemia research.
[18] Mei X. Wu,et al. Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Kumar,et al. IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes , 2001, Oncogene.
[20] Y. Miyakawa,et al. The Roles of Phosphatidylinositol 3-Kinase and Protein Kinase Cζ for Thrombopoietin-induced Mitogen-activated Protein Kinase Activation in Primary Murine Megakaryocytes* , 2001, The Journal of Biological Chemistry.
[21] F. Zintl,et al. Evidence for a novel thrombopoietin signalling event: activation of protein kinase A in human megakaryoblastic CMK cells. , 2001, Cytokine.
[22] I. Dusanter-Fourt,et al. Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo) , 2001, Oncogene.
[23] G. Krupp,et al. Functional disruption of IEX‐1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cells , 2001, FEBS letters.
[24] J. de Gunzburg,et al. Thrombopoietin-Mediated Sustained Activation of Extracellular Signal-Regulated Kinase in UT7-Mpl Cells Requires Both Ras–Raf-1- and Rap1–B-Raf-Dependent Pathways , 2001, Molecular and Cellular Biology.
[25] P. Charneau,et al. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] Y. Miyakawa,et al. Thrombopoietin Induces Phosphoinositol 3-Kinase Activation through SHP2, Gab, and Insulin Receptor Substrate Proteins in BAF3 Cells and Primary Murine Megakaryocytes* , 2001, The Journal of Biological Chemistry.
[27] M. Kurokawa,et al. Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis. , 2000, Blood.
[28] E. Macintyre,et al. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21 , 2000 .
[29] R. Yeager,et al. Pharmacokinetics and Hematological Effects of the PEGylated Thrombopoietin Peptide Mimetic GW395058 in Rats and Monkeys After Intravenous or Subcutaneous Administration , 1999, Stem cells.
[30] John M. Maris,et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.
[31] F. Porteu,et al. Megakaryocyte Growth and Development Factor-Induced Proliferation and Differentiation Are Regulated by the Mitogen-Activated Protein Kinase Pathway in Primitive Cord Blood Hematopoietic Progenitors , 1999 .
[32] K. Kaushansky,et al. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. , 1999, Blood.
[33] K. Kaushansky,et al. Thrombopoietin Signal Transduction Requires Functional JAK2, Not TYK2* , 1999, The Journal of Biological Chemistry.
[34] R. Kumar,et al. Regulation of a novel immediate early response gene, IEX-1, in keratinocytes by 1alpha,25-dihydroxyvitamin D3. , 1998, Biochemical and biophysical research communications.
[35] T. Hirano,et al. Involvement of Prolonged Ras Activation in Thrombopoietin-Induced Megakaryocytic Differentiation of a Human Factor-Dependent Hematopoietic Cell Line , 1998, Molecular and Cellular Biology.
[36] F.J. Sauvage,et al. Role of c-mpl in early hematopoiesis. , 1998, Blood.
[37] W. Deppert,et al. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene , 1998, Oncogene.
[38] A T Look,et al. Oncogenic transcription factors in the human acute leukemias. , 1997, Science.
[39] T. Vik,et al. Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells. , 1997, Blood.
[40] P. Gadue,et al. Activation of the Megakaryocyte-specific Gene Platelet Basic Protein (PBP) by the Ets Family Factor PU.1* , 1997, The Journal of Biological Chemistry.
[41] S. Goueli,et al. Sustained Activation of the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway Is Required for Megakaryocytic Differentiation of K562 Cells* , 1997, The Journal of Biological Chemistry.
[42] I. Dusanter-Fourt,et al. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway , 1997, Molecular and cellular biology.
[43] D. Baccanari,et al. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. , 1997, Science.
[44] N. Ahn,et al. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase , 1997, Molecular and cellular biology.
[45] K. Tanaka,et al. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability , 1996, Molecular and cellular biology.
[46] U. Fölsch,et al. PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line. , 1996, Cancer research.
[47] I. Dusanter-Fourt,et al. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin , 1996, Molecular and cellular biology.
[48] J. Downing,et al. AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.
[49] D. Levy,et al. Thrombopoietin activates a STAT5‐like factor in hematopoietic cells. , 1995, The EMBO journal.
[50] Gregory Riely,et al. Isolation and characterization of a TATA-less promoter for the human beta 3 integrin gene. , 1994, Blood.
[51] M. Wu. Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis , 2004, Apoptosis.
[52] H Phillip Koeffler,et al. Myelodysplastic Bone Marrow Cells from Normal and + Characterization of Gene Expression of Cd34 , 2002 .
[53] E. Macintyre,et al. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. , 2000, Blood.
[54] F. Porteu,et al. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. , 1999, Blood.
[55] M. Zutter,et al. Regulation of alpha 2 integrin gene expression in cells with megakaryocytic features: a common theme of three necessary elements. , 1995, Blood.